Abnormal α-synuclein aggregation is a key pathological feature of a group of
neurodegenerative diseases known as synucleinopathies, which include Parkinson's …

Several advances in fluid and tissue-based biomarkers for use in Parkinson's disease (PD)
and other synucleinopathies have been made in the last several years. While work …

A growing amount of evidence has indicated contributions of variants in causative genes of
Parkinson's disease (PD) to the development of sleep disturbance in PD and prodromal PD …

The possible usefulness of alpha-synuclein (aSyn) determinations in peripheral tissues
(blood cells, salivary gland biopsies, olfactory mucosa, digestive tract, skin) and in biological …

PURPOSE OF REVIEW Essential tremor is a chronic, progressive syndrome that primarily
presents with an action tremor involving the arms and hands. This article reviews the history …

Abstract Parkinson's disease (PD), the most common neurological motor system disorder,
which characterised by the irreversible loss of dopaminergic neurones in the substantia …

Parkinson's disease (PD) is a neurodegenerative disease characterized pathologically by
the formation of Lewy bodies comprised mainly of α-synuclein. Assessment of skin synuclein …

Background Cutaneous phosphorylated alpha-synuclein (p-α-syn) deposition is an
important biomarker of idiopathic Parkinson's disease (iPD). Recent studies have reported …

Parkinson's disease (PD) is a neurodegenerative disorder affecting 2–3% of those aged
over 65, characterized by motor symptoms like slow movement, tremors, and muscle rigidity …

ABSTRACT Background Patients with Parkinson's disease (PD) and GBA gene mutations
(GBA‐PD) develop nonmotor complications more frequently than noncarriers. However, an …